Sun Pharma
Search results
Built on the foundation of caring for life, Cipla ensures access to quality & affordable medicines through 1500+ products across various therapeutic categories.
Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions.
Cipla is a leading pharmaceutical company that provides affordable medicine to patients across geographies. Over the last 8 decades, we have been fortifying our promise of ‘Caring for Life'.
Make every life thrive. You will be inspired by our purpose and pioneering spirit at Cipla. Growth, to us, is meaningful when it is holistic and has an impact beyond ourselves. Inspiring Pioneers. Championing Care. Nourishing Careers. Search jobs.
9 hours ago · Umang Vohra, managing director & global chief executive officer, Cipla, said, “AMR is an urgent and serious healthcare challenge that needs global attention. With the rising incidence of potentially-life threatening infections, there is a strong need for novel anti-infectives in the effective treatment of MDR infections. This partnership enhances Cipla’s commitment to AMR stewardship and strengthens our efforts to combat infectious diseases and deliver advanced, innovative therapies to ...
3 days ago · Cipla Share Price: Find the latest news on Cipla Stock Price. Get all the information on Cipla with historic price charts for NSE / BSE.
Jun 21, 2024 · Cipla announced the agreement late on Thursday. Takeda has granted both drugmakers non-exclusive patent licensing rights for the drug. Gastroesophageal reflux disease (GERD) affects 5% to 28.5% of ...
11 hours ago · Discover the Cipla Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track of Cipla's latest details, including: Last traded price 1484.95, Market capitalization: 119554.91, Volume: 6030, Price-to-earnings ratio 29.01, Earnings per share 51.05. Our liveblog offers a holistic view of Cipla by examining both fundamental and technical indicators. Stay ahead of market trends with breakingnews that can impact Cipla's ...
3 days ago · Cipla Share Price Today (28 Jun, 2024): Cipla Stock Price (₹ 1480.80) Live NSE/BSE updates on The Economic Times. Check out why Cipla share price is down today. Get all details on Cipla shares news and analysis, Forecasts, Dividend, balance sheet, profit & loss, Quarterly results, annual report information, and more.
9 hours ago · The partnership between Orchid Pharma and Cipla combines Orchid's innovative drug development capabilities with Cipla's extensive distribution network and market presence, the company stated.
